"Metabolome" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The dynamic collection of metabolites which represent a cell's or organism's net metabolic response to current conditions.
| Descriptor ID |
D055442
|
| MeSH Number(s) |
G03.500
|
| Concept/Terms |
Metabolic Profile- Metabolic Profile
- Metabolic Profiles
- Profile, Metabolic
- Profiles, Metabolic
|
Below are MeSH descriptors whose meaning is more general than "Metabolome".
Below are MeSH descriptors whose meaning is more specific than "Metabolome".
This graph shows the total number of publications written about "Metabolome" by people in this website by year, and whether "Metabolome" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2011 | 1 | 1 | 2 |
| 2012 | 1 | 0 | 1 |
| 2014 | 0 | 1 | 1 |
| 2016 | 2 | 0 | 2 |
| 2017 | 37 | 23 | 60 |
| 2018 | 20 | 25 | 45 |
| 2019 | 8 | 4 | 12 |
| 2020 | 5 | 7 | 12 |
| 2021 | 5 | 5 | 10 |
To return to the timeline, click here.
Below are the most recent publications written about "Metabolome" by people in Profiles.
-
Distinct Metabolic Profile Associated with a Fatal Outcome in COVID-19 Patients during the Early Epidemic in Italy. Microbiol Spectr. 2021 10 31; 9(2):e0054921.
-
The COVIDome Explorer researcher portal. Cell Rep. 2021 08 17; 36(7):109527.
-
Longitudinal metabolomics of human plasma reveals prognostic markers of COVID-19 disease severity. Cell Rep Med. 2021 08 17; 2(8):100369.
-
Combined Metabolic Activators Accelerates Recovery in Mild-to-Moderate COVID-19. Adv Sci (Weinh). 2021 09; 8(17):e2101222.
-
A multi-omics investigation of the composition and function of extracellular vesicles along the temporal trajectory of COVID-19. Nat Metab. 2021 07; 3(7):909-922.
-
SARS-CoV-2-mediated dysregulation of metabolism and autophagy uncovers host-targeting antivirals. Nat Commun. 2021 06 21; 12(1):3818.
-
Pharmacogenomic considerations for repurposing of dexamethasone as a potential drug against SARS-CoV-2 infection. Per Med. 2021 07; 18(4):389-398.
-
Metabolite reanalysis revealed potential biomarkers for COVID-19: a potential link with immune response. Future Microbiol. 2021 05; 16:577-588.
-
Metabolic biomarker profiling for identification of susceptibility to severe pneumonia and COVID-19 in the general population. Elife. 2021 05 04; 10.
-
Metabolic Signatures Associated with Severity in Hospitalized COVID-19 Patients. Int J Mol Sci. 2021 Apr 30; 22(9).